{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:24:54Z","timestamp":1776119094887,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T00:00:00Z","timestamp":1554854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T00:00:00Z","timestamp":1554854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/1\/2(4)\/CVD\/2011\/NCD-II"],"award-info":[{"award-number":["3\/1\/2(4)\/CVD\/2011\/NCD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["Travel award"],"award-info":[{"award-number":["Travel award"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiorenal syndrome is defined by primary heart failure conditions influencing or leading to renal injury or dysfunction. Dilated cardiomyopathy (DCM) is a major co-existing form of heart failure (HF) with renal diseases. Myocardin (MYOCD), a cardiac-specific co-activator of serum response factor (SRF), is increased in DCM porcine and patient cardiac tissues and plays a crucial role in the pathophysiology of DCM. Inhibiting the increased MYOCD has shown to be partially rescuing the DCM phenotype in porcine model. However, expression levels of MYOCD in the cardiac tissues of the cardiorenal syndromic patients and the effect of inhibiting MYOCD in a cardiorenal syndrome model remains to be explored. Here, we analyzed the expression levels of MYOCD in the DCM patients with and without renal diseases. We also explored, whether cardiac specific silencing of MYOCD expression could ameliorate the cardiac remodeling and improve cardiac function in a renal artery ligated rat model (RAL). We observed an increase in MYOCD levels in the endomyocardial biopsies of DCM patients associated with renal failure compared to DCM alone. Silencing of MYOCD in RAL rats by a cardiac homing peptide conjugated MYOCD siRNA resulted in attenuation of cardiac hypertrophy, fibrosis and restoration of the left ventricular functions. Our data suggest hyper-activation of MYOCD in the pathogenesis of the cardiorenal failure cases. Also, MYOCD silencing showed beneficial effects by rescuing cardiac hypertrophy, fibrosis, size and function in a cardiorenal rat model.<\/jats:p>","DOI":"10.1038\/s41598-019-42009-z","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T06:18:48Z","timestamp":1554877128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Myocardin ablation in a cardiac-renal rat model"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-6599","authenticated-orcid":false,"given":"Anupam","family":"Mittal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6247-6280","authenticated-orcid":false,"given":"Santanu","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajni","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhilesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishikesh","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish K.","family":"Raut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagartirtha","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uma Nahar","family":"Saikia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Bahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7831-9570","authenticated-orcid":false,"given":"Perundurai S.","family":"Dhandapany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhu","family":"Khullar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,10]]},"reference":[{"key":"42009_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","volume":"10","author":"RE Hershberger","year":"2013","unstructured":"Hershberger, R. E., Hedges, D. J. & Morales, A. Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat. Rev. Cardiol. 10, 531\u2013547 (2013).","journal-title":"Nat. Rev. Cardiol."},{"key":"42009_CR2","doi-asserted-by":"publisher","first-page":"17985","DOI":"10.1073\/pnas.0605545103","volume":"103","author":"SD Crowley","year":"2006","unstructured":"Crowley, S. D. et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc. Natl. Acad. Sci. 103, 17985\u201317990 (2006).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"119","key":"42009_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/CS20100084","volume":"1979","author":"C-Z Chiu","year":"2010","unstructured":"Chiu, C.-Z., Wang, B.-W., Chung, T.-H. & Shyu, K.-G. Angiotensin II and the ERK pathway mediate the induction of myocardin by hypoxia in cultured rat neonatal cardiomyocytes. Clin. Sci. Lond. Engl. 1979(119), 273\u2013282 (2010).","journal-title":"Clin. Sci. Lond. Engl."},{"key":"42009_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0092-8674(01)00404-4","volume":"105","author":"D Wang","year":"2001","unstructured":"Wang, D. et al. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 105, 851\u2013862 (2001).","journal-title":"Cell"},{"key":"42009_CR5","doi-asserted-by":"publisher","first-page":"18734","DOI":"10.1073\/pnas.0910749106","volume":"106","author":"J Huang","year":"2009","unstructured":"Huang, J. et al. Myocardin is required for cardiomyocyte survival and maintenance of heart function. Proc. Natl. Acad. Sci. 106, 18734\u201318739 (2009).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"42009_CR6","doi-asserted-by":"publisher","first-page":"55626","DOI":"10.1074\/jbc.M405945200","volume":"279","author":"X Zhang","year":"2004","unstructured":"Zhang, X., Azhar, G., Zhong, Y. & Wei, J. Y. Identification of a novel serum response factor cofactor in cardiac gene regulation. J. Biol. Chem. 279, 55626\u201355632 (2004).","journal-title":"J. Biol. Chem."},{"key":"42009_CR7","first-page":"515","volume":"118","author":"J Huang","year":"2008","unstructured":"Huang, J. et al. Myocardin regulates expression of contractile genes in smooth muscle cells and is required for closure of the ductus arteriosus in mice. J. Clin. Invest. 118, 515\u2013525 (2008).","journal-title":"J. Clin. Invest."},{"key":"42009_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cardiores.2005.04.013","volume":"67","author":"J van Tuyn","year":"2005","unstructured":"van Tuyn, J. et al. Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardin. Cardiovasc. Res. 67, 245\u2013255 (2005).","journal-title":"Cardiovasc. Res."},{"key":"42009_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ccr.2006.11.022","volume":"11","author":"M Milyavsky","year":"2007","unstructured":"Milyavsky, M. et al. Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defect. Cancer Cell 11, 133\u2013146 (2007).","journal-title":"Cancer Cell"},{"key":"42009_CR10","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1128\/MCB.01160-06","volume":"27","author":"J Wang","year":"2007","unstructured":"Wang, J. et al. Myocardin sumoylation transactivates cardiogenic genes in pluripotent 10T1\/2 fibroblasts. Mol. Cell. Biol. 27, 622\u2013632 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"42009_CR11","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1038\/jid.2011.219","volume":"131","author":"BJ Crider","year":"2011","unstructured":"Crider, B. J., Risinger, G. M., Haaksma, C. J., Howard, E. W. & Tomasek, J. J. Myocardin-related transcription factors A and B are key regulators of TGF-\u03b21-induced fibroblast to myofibroblast differentiation. J. Invest. Dermatol. 131, 2378\u20132385 (2011).","journal-title":"J. Invest. Dermatol."},{"key":"42009_CR12","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1161\/01.RES.0000218781.23144.3e","volume":"98","author":"W Xing","year":"2006","unstructured":"Xing, W. et al. Myocardin induces cardiomyocyte hypertrophy. Circ. Res. 98, 1089\u20131097 (2006).","journal-title":"Circ. Res."},{"key":"42009_CR13","doi-asserted-by":"publisher","first-page":"11903","DOI":"10.1074\/jbc.M109.098004","volume":"285","author":"K Wang","year":"2010","unstructured":"Wang, K., Long, B., Zhou, J. & Li, P.-F. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy. J. Biol. Chem. 285, 11903\u201311912 (2010).","journal-title":"J. Biol. Chem."},{"key":"42009_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s00109-003-0470-7","volume":"81","author":"M Torrado","year":"2003","unstructured":"Torrado, M. et al. Myocardin mRNA is augmented in the failing myocardium: expression profiling in the porcine model and human dilated cardiomyopathy. J. Mol. Med. Berl. Ger. 81, 566\u2013577 (2003).","journal-title":"J. Mol. Med. Berl. Ger."},{"key":"42009_CR15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/eurjhf\/hfq057","volume":"12","author":"JE Kontaraki","year":"2010","unstructured":"Kontaraki, J. E., Parthenakis, F. I., Nyktari, E. G., Patrianakos, A. P. & Vardas, P. E. Myocardial gene expression alterations in peripheral blood mononuclear cells of patients with idiopathic dilated cardiomyopathy. Eur. J. Heart Fail. 12, 541\u2013548 (2010).","journal-title":"Eur. J. Heart Fail."},{"key":"42009_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11010-016-2666-5","volume":"414","author":"A Mittal","year":"2016","unstructured":"Mittal, A., Sharma, R., Prasad, R., Bahl, A. & Khullar, M. Role of cardiac TBX20 in dilated cardiomyopathy. Mol. Cell. Biochem. 414, 129\u2013136 (2016).","journal-title":"Mol. Cell. Biochem."},{"key":"42009_CR17","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1074\/jbc.M111.246173","volume":"287","author":"SA Mir","year":"2012","unstructured":"Mir, S. A. et al. Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart. J. Biol. Chem. 287, 2666\u20132677 (2012).","journal-title":"J. Biol. Chem."},{"key":"42009_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jconrel.2015.01.008","volume":"200","author":"S Rana","year":"2015","unstructured":"Rana, S. et al. A spatio-temporal cardiomyocyte targeted vector system for efficient delivery of therapeutic payloads to regress cardiac hypertrophy abating bystander effect. J. Control. Release Off. J. Control. Release Soc. 200, 167\u2013178 (2015).","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"42009_CR19","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/0022-2828(92)93391-V","volume":"24","author":"K Shivakumar","year":"1992","unstructured":"Shivakumar, K., Nair, R. R. & Valiathan, M. S. Paradoxical effect of cerium on collagen synthesis in cardiac fibroblasts. J. Mol. Cell. Cardiol. 24, 775\u2013780 (1992).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"42009_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/1874192401004010257","volume":"4","author":"RC Grossman","year":"2010","unstructured":"Grossman, R. C. Experimental models of renal disease and the cardiovascular system. Open Cardiovasc. Med. J. 4, 257\u2013264 (2010).","journal-title":"Open Cardiovasc. Med. J."},{"key":"42009_CR21","doi-asserted-by":"publisher","first-page":"R451","DOI":"10.1152\/ajpregu.00353.2016","volume":"312","author":"JS Clemmer","year":"2017","unstructured":"Clemmer, J. S., Pruett, W. A., Coleman, T. G., Hall, J. E. & Hester, R. L. Mechanisms of blood pressure salt sensitivity: new insights from mathematical modeling. Am. J. Physiol.-Regul. Integr. Comp. Physiol. 312, R451\u2013R466 (2017).","journal-title":"Am. J. Physiol.-Regul. Integr. Comp. Physiol."},{"key":"42009_CR22","unstructured":"TGF-\u03b2-induced epithelial to mesenchymal transition | Cell Research. Available at, https:\/\/www.nature.com\/articles\/cr20095 (Accessed: 18th April 2018)."},{"key":"42009_CR23","doi-asserted-by":"publisher","first-page":"e26392","DOI":"10.1371\/journal.pone.0026392","volume":"6","author":"M Torrado","year":"2011","unstructured":"Torrado, M., Iglesias, R., Centeno, A., L\u00f3pez, E. & Mikhailov, A. T. Targeted Gene-Silencing Reveals the Functional Significance of Myocardin Signaling in the Failing Heart. PLoS ONE 6, e26392 (2011).","journal-title":"PLoS ONE"},{"key":"42009_CR24","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1161\/ATVBAHA.118.311171","volume":"38","author":"Q Lyu","year":"2018","unstructured":"Lyu, Q. et al. CRISPR-Cas9-Mediated Epitope Tagging Provides Accurate and Versatile Assessment of Myocardin-Brief Report. Arterioscler. Thromb. Vasc. Biol. 38, 2184\u20132190 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42009-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42009-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42009-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T03:34:38Z","timestamp":1671248078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-42009-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,10]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["42009"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-42009-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/470708","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,10]]},"assertion":[{"value":"18 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5872"}}